Cargando…
Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma
Background: Epigenetic dysregulation has been increasingly proposed as a hallmark of cancer. Here, the aim of this study is to establish an epigenetic-related signature for predicting the prognosis of lung adenocarcinoma (LUAD) patients. Results: Five epigenetic-related genes (ERGs) (ARRB1, PARP1, P...
Autores principales: | Wang, Zhihao, Embaye, Kidane Siele, Yang, Qing, Qin, Lingzhi, Zhang, Chao, Liu, Liwei, Zhan, Xiaoqian, Zhang, Fengdi, Wang, Xi, Qin, Shenghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351720/ https://www.ncbi.nlm.nih.gov/pubmed/34285141 http://dx.doi.org/10.18632/aging.203315 |
Ejemplares similares
-
A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma
por: Wang, Zhihao, et al.
Publicado: (2021) -
Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genes
por: Wang, Zhihao, et al.
Publicado: (2021) -
Clinico-pathologic determinants of non-e-curative outcome following en-bloc endoscopic submucosal dissection in patients with early gastric neoplasia
por: Embaye, Kidane Siele, et al.
Publicado: (2021) -
A novel prognostic signature of metastasis-associated genes and personalized therapeutic strategy for lung adenocarcinoma patients
por: Wang, Zhihao, et al.
Publicado: (2022) -
The Implication of STEP in Synaptic Plasticity and Cognitive Impairments in Alzheimer’s Disease and Other Neurological Disorders
por: Mahaman, Yacoubou Abdoul Razak, et al.
Publicado: (2021)